Kimia Biosciences Ltd vs Sanjivani Paranteral Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 19, 2026

Key Highlights

The Latest Trading Price of Kimia Biosciences Ltd is ₹ 36.05 as of 18 May 15:30 . The P/E Ratio of Kimia Biosciences Ltd is 0 as of March 2024 .The P/E Ratio of Sanjivani Paranteral Ltd is 28.4 as of March 2024 . The Market Cap of Kimia Biosciences Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Sanjivani Paranteral Ltd is ₹ 175.32 crore as of March 2024 . The revenue of Kimia Biosciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 13.81 crore as compare to the Dec '25 revenue of ₹ 22.36 crore. This represent the decline of -38.24% The ebitda of Kimia Biosciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanjivani Paranteral Ltd for the Mar '26 is ₹ 2.17 crore as compare to the Dec '25 ebitda of ₹ 4.13 crore. This represent the decline of -47.46% The net profit of Kimia Biosciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Sanjivani Paranteral Ltd changed from ₹ 1.71 crore to ₹ 0.55 crore over 8 quarters. This represents a CAGR of -43.29% The Dividend Payout of Kimia Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sanjivani Paranteral Ltd changed from 7.33 % on March 2025 to 7.33 % on March 2025 . This represents a CAGR of 0.00% over 1 years .

About Kimia Biosciences Ltd

Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993.
The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
The name of the Company was changed from 'Laurel Organics Limited' to 'Kimia Biosciences Limited' w.e..f 4 January, 2019.
Since then, it engages in the business of Pharmaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
It came out with a public issue in Feb.'95 to part-finance the project.

About Sanjivani Paranteral Ltd

Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
The Company is involved in the manufacturing of pharmaceutical medicines.
Its products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

FAQs for the comparison of Kimia Biosciences Ltd and Sanjivani Paranteral Ltd

Which company has a larger market capitalization, Kimia Biosciences Ltd or Sanjivani Paranteral Ltd?

Market cap of Kimia Biosciences Ltd is 170 Cr while Market cap of Sanjivani Paranteral Ltd is 164 Cr

What are the key factors driving the stock performance of Kimia Biosciences Ltd and Sanjivani Paranteral Ltd?

The stock performance of Kimia Biosciences Ltd and Sanjivani Paranteral Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kimia Biosciences Ltd and Sanjivani Paranteral Ltd?

As of May 19, 2026, the Kimia Biosciences Ltd stock price is INR ₹36.05. On the other hand, Sanjivani Paranteral Ltd stock price is INR ₹133.75.

How do dividend payouts of Kimia Biosciences Ltd and Sanjivani Paranteral Ltd compare?

To compare the dividend payouts of Kimia Biosciences Ltd and Sanjivani Paranteral Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.